Study to Evaluate TV-46000 as Maintenance Treatment in Participants With Schizophrenia

Study Title
Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia
Teva Identifier
TV46000-CNS-30072 | 03503318 | 2018-001619-65
ClinicalTrials.gov Identifier
NCT03503318
Study Status
Completed
Trial Condition(s)
Schizophrenia
Interventions
Drug: TV-46000 - A | Drug: TV-46000 - B | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Child, Adult, Older Adult
Age Range
13 Years to 65 Years
Trial Duration
April 27, 2018 - December 3, 2020
Phase
Phase 3

Additional info

Study Type

Interventional